CYTOSORBENTS CORPORATION Cash and Cash Equivalents, Period Increase (Decrease)
CYTOSORBENTS CORPORATION (CTSO) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.72 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-07
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$2.72M, a 172.23% decline year-over-year.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$2.54M, a 232.31% decline year-over-year.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$371.36K.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $4.19M, a 68.14% decline year-over-year.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2018 was $5.05M, a 58.21% decline from fiscal 2017.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2017 was $12.08M.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$71.67K, a 104.19% decline from fiscal 2015.
- CYTOSORBENTS CORPORATION cash and cash equivalents, period increase (decrease) for fiscal 2015 was $1.71M, a 20.34% increase from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 173 month | Cash and Cash Equivalents, Period Increase (Decrease) 176 month | Cash and Cash Equivalents, Period Increase (Decrease) 179 month | Cash and Cash Equivalents, Period Increase (Decrease) 182 month | Cash and Cash Equivalents, Period Increase (Decrease) 185 month | Cash and Cash Equivalents, Period Increase (Decrease) 188 month | Cash and Cash Equivalents, Period Increase (Decrease) 191 month | Cash and Cash Equivalents, Period Increase (Decrease) 194 month | Cash and Cash Equivalents, Period Increase (Decrease) 197 month | Cash and Cash Equivalents, Period Increase (Decrease) 200 month | Cash and Cash Equivalents, Period Increase (Decrease) 203 month | Cash and Cash Equivalents, Period Increase (Decrease) 206 month | Cash and Cash Equivalents, Period Increase (Decrease) 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$2.72M 10-Q · filed 2019-05-07 | -$5.26M derived: sum of 2 quarters · filed 2019-05-07 | -$5.64M derived: sum of 3 quarters · filed 2019-05-07 | -$1.44M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2018-12-31 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$2.91M derived: sum of 2 quarters · filed 2019-03-07 | $1.28M derived: sum of 3 quarters · filed 2019-03-07 | $5.05M 10-K · filed 2019-03-07 | |||||||||||||
| 2018-09-30 | -$371.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $3.82M derived: sum of 2 quarters · filed 2018-11-06 | $7.59M 10-Q · filed 2018-11-06 | $9.51M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2018-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $7.96M 10-Q · filed 2018-08-02 | $9.88M derived: sum of 3 quarters · filed 2019-05-07 | $8.88M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2018-03-31 | $3.77M 10-Q · filed 2019-05-07 | $5.69M derived: sum of 2 quarters · filed 2019-05-07 | $4.69M derived: sum of 3 quarters · filed 2019-05-07 | $17.85M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $919.53K derived: sum of 2 quarters · filed 2019-03-07 | $14.08M derived: sum of 3 quarters · filed 2019-03-07 | $12.08M 10-K · filed 2019-03-07 | |||||||||||||
| 2017-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $12.16M derived: sum of 2 quarters · filed 2018-11-06 | $10.16M 10-Q · filed 2018-11-06 | $9.03M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2017-06-30 | $13.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $11.16M 10-Q · filed 2018-08-02 | $10.03M derived: sum of 3 quarters · filed 2019-03-07 | $7.73M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2017-03-31 | -$2.01M 10-Q · filed 2018-05-08 | -$3.14M derived: sum of 2 quarters · filed 2019-03-07 | -$5.43M derived: sum of 3 quarters · filed 2019-03-07 | -$297.44K derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||
| 2016-12-31 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$3.43M derived: sum of 2 quarters · filed 2019-03-07 | $1.71M derived: sum of 3 quarters · filed 2019-03-07 | -$71.67K 10-K · filed 2019-03-07 | |||||||||||||
| 2016-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.84M derived: sum of 2 quarters · filed 2017-11-09 | $1.06M 10-Q · filed 2017-11-09 | -$1.01M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||
| 2016-06-30 | $5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $3.35M 10-Q · filed 2017-08-07 | $1.28M derived: sum of 3 quarters · filed 2018-03-08 | $653.05K derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||
| 2016-03-31 | -$1.78M 10-Q · filed 2017-05-08 | -$3.85M derived: sum of 2 quarters · filed 2018-03-08 | -$4.48M derived: sum of 3 quarters · filed 2018-03-08 | -$6.88M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||
| 2015-12-31 | -$2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$2.70M derived: sum of 2 quarters · filed 2018-03-08 | -$5.10M derived: sum of 3 quarters · filed 2018-03-08 | $1.71M 10-K · filed 2018-03-08 | |||||||||||||
| 2015-09-30 | -$631.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$3.03M derived: sum of 2 quarters · filed 2016-11-07 | $3.78M 10-Q · filed 2016-11-07 | $6.95M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||
| 2015-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.41M 10-Q · filed 2016-08-09 | $7.58M derived: sum of 3 quarters · filed 2017-03-03 | $3.14M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||
| 2015-03-31 | $6.81M 10-Q · filed 2016-05-09 | $9.99M derived: sum of 2 quarters · filed 2017-03-03 | $5.54M derived: sum of 3 quarters · filed 2017-03-03 | $4.00M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||
| 2014-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$1.27M derived: sum of 2 quarters · filed 2017-03-03 | -$2.81M derived: sum of 3 quarters · filed 2017-03-03 | $1.42M 10-K · filed 2017-03-03 | |||||||||||||
| 2014-09-30 | -$4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$5.98M derived: sum of 2 quarters · filed 2015-11-13 | -$1.75M 10-Q · filed 2015-11-13 | -$1.92M derived: sum of 4 quarters · filed 2015-11-13 | |||||||||||||
| 2014-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $2.70M 10-Q · filed 2015-08-13 | $2.53M derived: sum of 3 quarters · filed 2015-08-13 | $3.01M derived: sum of 4 quarters · filed 2015-08-13 | $4.88M 10-Q · filed 2014-08-12 | ||||||||||||
| 2014-03-31 | $4.23M 10-Q · filed 2015-05-11 | $4.07M derived: sum of 2 quarters · filed 2015-05-11 | $4.55M derived: sum of 3 quarters · filed 2015-05-11 | $5.05M derived: sum of 4 quarters · filed 2015-05-11 | $6.42M 10-Q · filed 2014-05-14 | ||||||||||||
| 2013-12-31 | -$166.96K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $312.42K derived: sum of 2 quarters · filed 2015-03-31 | $817.74K derived: sum of 3 quarters · filed 2015-03-31 | $453.69K 10-K · filed 2015-03-31 | $2.18M 10-K · filed 2014-03-31 | ||||||||||||
| 2013-09-30 | $479.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $984.70K derived: sum of 2 quarters · filed 2014-11-12 | $620.65K 10-Q · filed 2014-11-12 | $288.86K derived: sum of 4 quarters · filed 2014-11-12 | $2.35M 10-Q · filed 2013-11-06 | ||||||||||||
| 2013-06-30 | $505.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $141.27K 10-Q · filed 2014-08-12 | -$190.52K derived: sum of 3 quarters · filed 2014-08-12 | $128.77K derived: sum of 4 quarters · filed 2014-08-12 | $1.87M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | -$364.05K 10-Q · filed 2014-05-14 | -$695.84K derived: sum of 2 quarters · filed 2014-05-14 | -$376.54K derived: sum of 3 quarters · filed 2014-05-14 | -$437.75K derived: sum of 4 quarters · filed 2014-05-14 | $1.37M 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | -$331.79K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$12.49K derived: sum of 2 quarters · filed 2014-03-31 | -$73.70K derived: sum of 3 quarters · filed 2014-03-31 | $542.69K 10-K · filed 2014-03-31 | $1.73M 10-K · filed 2013-04-03 | ||||||||||||
| 2012-09-30 | $319.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $258.08K derived: sum of 2 quarters · filed 2013-11-06 | $874.48K 10-Q · filed 2013-11-06 | -$235.01K derived: sum of 4 quarters · filed 2013-11-06 | $2.06M 10-Q · filed 2012-11-21 | ||||||||||||
| 2012-06-30 | -$61.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $555.19K 10-Q · filed 2013-08-14 | -$554.31K derived: sum of 3 quarters · filed 2013-08-14 | -$1.67M derived: sum of 4 quarters · filed 2013-08-14 | $1.74M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $616.40K 10-Q · filed 2013-05-15 | -$493.10K derived: sum of 2 quarters · filed 2013-05-15 | -$1.61M derived: sum of 3 quarters · filed 2013-05-15 | -$633.42K derived: sum of 4 quarters · filed 2013-05-15 | $1.80M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-03 | -$2.23M derived: sum of 2 quarters · filed 2013-04-03 | -$1.25M derived: sum of 3 quarters · filed 2013-04-03 | $130.98K 10-K · filed 2013-04-03 | $1.19M 10-K · filed 2012-03-30 | ||||||||||||
| 2011-09-30 | -$1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-21 | -$140.32K derived: sum of 2 quarters · filed 2012-11-21 | $1.24M 10-Q · filed 2012-11-21 | $1.54M derived: sum of 4 quarters · filed 2012-11-21 | $2.30M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $980.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $2.36M 10-Q · filed 2012-08-13 | $2.66M derived: sum of 3 quarters · filed 2012-08-13 | $2.82M derived: sum of 4 quarters · filed 2012-08-13 | $3.42M 10-Q · filed 2011-08-15 | ||||||||||||
| 2011-03-31 | $1.38M 10-Q · filed 2012-05-15 | $1.68M derived: sum of 2 quarters · filed 2012-05-15 | $1.84M derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||||
| 2010-12-31 | $297.44K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $460.14K derived: sum of 2 quarters · filed 2012-03-30 | -$539.96K 10-K · filed 2012-03-30 | ||||||||||||||
| 2010-09-30 | $162.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$837.40K 10-Q · filed 2011-11-14 | |||||||||||||||
| 2010-06-30 | -$1.00M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |